Chinese Surgical Robot Maker Jianjia Robots Picks Up RMB100M Series B

Baidu-backed Jianjia’s ‘Arthrobot’ is currently undergoing clinical trials

 

 

Chinese intelligent orthopedic surgical robot developer Jianjia Robots has raised a Series B round of over RMB100 million (US$14.62 million at current rates), according to a statement released by financial advisor to the deal Haoyue Capital.

 

The funding was raised from Beijing-based private equity firm Hillhouse Capital, Chinese pharma Fosun Pharma, and Chinese Internet company Baidu’s corporate venture arm Baidu Ventures, the statement said.

 

The 2018-founded company will utilize the fresh capital to facilitate the clinical registration of its existing joint replacement surgical robots as well as to develop new products, the statement noted.

 

Baidu Ventures had earlier led the startup’s Series A round at early this year with Haoyue Capital as the exclusive financial advisor to the deal. The round was aimed to enable clinical trials of Jianjia’s first joint replacement surgery robot called ‘Arthrobot’.

 

Joint replacement is a surgery performed to replace joints that are damaged or disabled with plastic or metal implants that function as artificial joints.

 

The statement noted that Jianjia’s Arthrobot is China’s first locally developed hip replacement surgical robot. The robot is able to execute precise positioning, polishing and prosthesis installation in the acetabular (hip joint socket) area of the body, as well as the femoral (around the femur) area.

 

“The intelligent surgical robot system, as a new capability platform to improve the quality and efficiency of surgical operations, has proven its huge clinical potential and will follow the rapid development of AI perception [and] computing,” a Baidu Ventures executive said in the statement.

 

The executive noted that Jianjia emerged out of China’s 863 Program also known as the State High-Tech Development Plan. The 863 Program was a state-backed program promoting domestically developed technologies. The program culminated in 2016.

 

A spokesperson from Fosun Pharma noted in the statement that joint surgery robots help to overcome uncertainties in joint replacement surgery, enabling them to be minimally invasive and consistent with surgical results.

 

“At present, the success of joint replacement surgery depends very much on the experience and surgical skills of doctors,” Jianjia’s Founder Xu Jing said, adding that joint surgery robots will be a “breakthrough to improve the accuracy of prosthesis implantation and boost the volume of joint replacement surgery.”

 

He added that Jianjia “will accelerate [the development of] orthopedic surgery robots with the help of capital. The clinical trials and R&D process of the company will build a surgical robot platform enterprise and become a supplier and leader of overall solutions and personalized diagnosis and treatment for orthopedic surgery in China.”

 

While one report suggests that the global market for surgical robots is expected to grow to $12.6 billion by 2025, only about 2.5 times its 2017 market value of $5.1 billion, another notes that growth in this industry may, in fact, decline in 2020, dropping to $4.84 billion, due to COVID-19.

 

The technology is still young and costly, but is expected to drive major transformation in the healthcare industry as it evolves.

 

Header image by Photos Hobby on Unsplash

SHARE THIS STORY

Share on facebook
Share on twitter
Share on linkedin
Share on email

RELATED POSTS

Hello Group Introduces inSpaze: An Immersive Social App for Apple Vision Pro

Hello Group Inc., a prominent mobile social entertainment provider in China, introduces its immersive social application, inSpaze, an immersive social application exclusively for Apple Vision Pro users in the United States. This application, crafted for visionOS, leverages advanced technologies like 3Ds, Reality Converter and Reality Composer Pro, offering a unique spatial computing experience that connects users worldwide through Spatial Audio and 3D interactive content.

Are There More Layoffs Coming in 2024?

Even as we kick off the new year, the horrors of the year past are not behind us. In 2023, major tech companies undertook big layoffs—in January last year, Google reduced its headcount by 6% (it also recently hinted at a fresh round of layoffs this year); in December 2023, Spotify laid off 17% of its staff and more companies gave out pink slips. This trend has been ongoing for a couple of years since the pandemic shook global markets.

GuideGeek Expands to Facebook Messenger to Offer Personalized Travel Tips

GuideGeek, Matador Network’s AI travel assistant powered by OpenAI, is now accessible to Facebook Messenger users, expanding its reach beyond WhatsApp and Instagram. This move aims to place GuideGeek in the hands of more travelers globally, offering instant, personalized travel tips at no cost.

Elon Musk’s Neuralink Debuts Brain Chip Implant: A Bold Future with Ethical Questions

Elon Musk’s Neuralink is back in the spotlight with a major update: they’ve put a brain chip, called the Link, into a human for the first time. This small device has set its sights on monumental goals, such as helping people who’ve lost their limb functionality. Musk’s big dream doesn’t stop there—he wants the chip to boost our brains, improve our memory and eventually blend the human mind with artificial intelligence (AI).

Mercedes-Benz Launches the New Luxurious CLE Cabriolet

Mercedes-Benz has launched the CLE Cabriolet, building on its heritage of creating four-seater convertible vehicles. This new addition is characterized by its expressive design, advanced technology, and high-quality features, ensuring an enhanced driving experience. The model, which evolves from the CLE Coupé, stands out with its traditional fabric acoustic soft top and distinct high-quality details, making it uniquely positioned in the market. Designed to offer dynamic performance alongside exceptional daily comfort, the CLE Cabriolet supports year-round open-air enjoyment.